These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
477 related articles for article (PubMed ID: 35623658)
1. Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy. Jiang X; Wang J; Zheng X; Liu Z; Zhang X; Li Y; Wilhelm J; Cao J; Huang G; Zhang J; Sumer B; Lea J; Lu Z; Gao J; Luo M J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35623658 [TBL] [Abstract][Full Text] [Related]
2. Synergistic STING activation by PC7A nanovaccine and ionizing radiation improves cancer immunotherapy. Luo M; Liu Z; Zhang X; Han C; Samandi LZ; Dong C; Sumer BD; Lea J; Fu YX; Gao J J Control Release; 2019 Apr; 300():154-160. PubMed ID: 30844475 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases. Mauldin IS; Wages NA; Stowman AM; Wang E; Smolkin ME; Olson WC; Deacon DH; Smith KT; Galeassi NV; Chianese-Bullock KA; Dengel LT; Marincola FM; Petroni GR; Mullins DW; Slingluff CL Cancer Immunol Immunother; 2016 Oct; 65(10):1189-99. PubMed ID: 27522581 [TBL] [Abstract][Full Text] [Related]
4. A STING-activating nanovaccine for cancer immunotherapy. Luo M; Wang H; Wang Z; Cai H; Lu Z; Li Y; Du M; Huang G; Wang C; Chen X; Porembka MR; Lea J; Frankel AE; Fu YX; Chen ZJ; Gao J Nat Nanotechnol; 2017 Jul; 12(7):648-654. PubMed ID: 28436963 [TBL] [Abstract][Full Text] [Related]
5. Antigen epitope-TLR7/8a conjugate as self-assembled carrier-free nanovaccine for personalized immunotherapy. Song H; Su Q; Shi W; Huang P; Zhang C; Zhang C; Liu Q; Wang W Acta Biomater; 2022 Mar; 141():398-407. PubMed ID: 35007785 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel DEC-205 binding peptide to develop dendritic cell-targeting nanovaccine for cancer immunotherapy. Zheng J; Wang M; Pang L; Wang S; Kong Y; Zhu X; Zhou X; Wang X; Chen C; Ning H; Zhao W; Zhai W; Qi Y; Wu Y; Gao Y J Control Release; 2024 Sep; 373():568-582. PubMed ID: 39067792 [TBL] [Abstract][Full Text] [Related]
7. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists. Baljon JJ; Kwiatkowski AJ; Pagendarm HM; Stone PT; Kumar A; Bharti V; Schulman JA; Becker KW; Roth EW; Christov PP; Joyce S; Wilson JT ACS Nano; 2024 Mar; 18(9):6845-6862. PubMed ID: 38386282 [TBL] [Abstract][Full Text] [Related]
8. STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity. Rossi M; Carboni S; Di Berardino-Besson W; Riva E; Santiago-Raber ML; Belnoue E; Derouazi M Front Immunol; 2021; 12():695056. PubMed ID: 34276686 [TBL] [Abstract][Full Text] [Related]
9. Self-degradable poly(β-amino ester)s promote endosomal escape of antigen and agonist. Liu H; Hu Z; Chen H; Yan Y; Le Z; Wei C; Cao W; Chen T; Chen Y; Liu L J Control Release; 2022 May; 345():91-100. PubMed ID: 35259460 [TBL] [Abstract][Full Text] [Related]
10. Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T Hou Y; Kong F; Tang Z; Zhang R; Li D; Ge J; Yu Z; Wahab A; Zhang Y; Iqbal MZ; Kong X J Control Release; 2024 Sep; 373():547-563. PubMed ID: 39059501 [TBL] [Abstract][Full Text] [Related]
11. Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response. Zhang L; Huang J; Chen X; Pan C; He Y; Su R; Guo D; Yin S; Wang S; Zhou L; Chen J; Zheng S; Qiao Y J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34452929 [TBL] [Abstract][Full Text] [Related]
12. Elastic Nanovaccine Enhances Dendritic Cell-Mediated Tumor Immunotherapy. Li Q; Teng Z; Tao J; Shi W; Yang G; Zhang Y; Su X; Chen L; Xiu W; Yuwen L; Dong H; Mou Y Small; 2022 Aug; 18(32):e2201108. PubMed ID: 35734820 [TBL] [Abstract][Full Text] [Related]
13. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10. Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349 [TBL] [Abstract][Full Text] [Related]
14. PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model. Peng S; Tan M; Li YD; Cheng MA; Farmer E; Ferrall L; Gaillard S; Roden RBS; Hung CF; Wu TC Cancer Immunol Immunother; 2021 Apr; 70(4):1049-1062. PubMed ID: 33108473 [TBL] [Abstract][Full Text] [Related]
15. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer. Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344 [TBL] [Abstract][Full Text] [Related]
16. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy. Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739 [TBL] [Abstract][Full Text] [Related]
17. Nanovaccine that activates the NLRP3 inflammasome enhances tumor specific activation of anti-cancer immunity. Manna S; Maiti S; Shen J; Weiss A; Mulder E; Du W; Esser-Kahn AP Biomaterials; 2023 May; 296():122062. PubMed ID: 36863071 [TBL] [Abstract][Full Text] [Related]
18. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control. Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048 [TBL] [Abstract][Full Text] [Related]
19. Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma. Saenger YM; Li Y; Chiou KC; Chan B; Rizzuto G; Terzulli SL; Merghoub T; Houghton AN; Wolchok JD Cancer Res; 2008 Dec; 68(23):9884-91. PubMed ID: 19047169 [TBL] [Abstract][Full Text] [Related]
20. Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer. Zhou L; Hou B; Wang D; Sun F; Song R; Shao Q; Wang H; Yu H; Li Y Nano Lett; 2020 Jun; 20(6):4393-4402. PubMed ID: 32459969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]